In a recent study on the genome-wide CRISPER/Cas9 knockout screen in acute myeloid leukemia (AML) cells, BEND3 knockout showed resistance to TAK-243, an inhibitor of ubiquitin-like modifier-activating enzyme 1. The gene discussed is UBA1; the disease is acute myeloid leukemia.